Corrigan G D, Pantig-Felix L, Kanat I O
J Am Podiatr Med Assoc. 1989 Dec;79(12):605-14. doi: 10.7547/87507315-79-12-605.
Since indomethacin was first marketed, some 40 years ago, the class of nonsteroidal anti-inflammatory drugs has grown larger than any other drug class in history. At present, there are at least 25 such drugs being used in the US and abroad, both clinically and in research. Despite their widespread use, their implications to health care are just beginning to be understood. The authors review updated theories on the mechanism of action, side effects, and drug interactions of nonsteroidal anti-inflammatory drug therapy. Proposed guidelines for monitoring their use are given. A more thorough understanding of the risks-to-benefits ratio is provided in an effort to achieve maximum patient satisfaction and safety.
大约40年前消炎痛首次上市以来,非甾体抗炎药类别已发展成为历史上比其他任何药物类别都要庞大的类别。目前,美国国内外临床和研究中至少有25种此类药物正在使用。尽管它们被广泛使用,但它们对医疗保健的影响才刚刚开始被人们所理解。作者回顾了关于非甾体抗炎药治疗作用机制、副作用和药物相互作用的最新理论。给出了监测其使用的建议指南。为了实现患者最大程度的满意度和安全性,对风险效益比进行了更全面的理解。